Cargando…
Epigallocatechin-3-gallate treatment to promote neuroprotection and functional recovery after nervous system injury
Autores principales: | Boadas-Vaello, Pere, Verdú, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625495/ https://www.ncbi.nlm.nih.gov/pubmed/26604890 http://dx.doi.org/10.4103/1673-5374.165502 |
Ejemplares similares
-
Novel Epigallocatechin-3-Gallate (EGCG) Derivative as a New Therapeutic Strategy for Reducing Neuropathic Pain after Chronic Constriction Nerve Injury in Mice
por: Xifró, Xavier, et al.
Publicado: (2015) -
Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise
por: Verdú, Enrique, et al.
Publicado: (2021) -
Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice
por: Castany, Sílvia, et al.
Publicado: (2018) -
Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice
por: Castany, Sílvia, et al.
Publicado: (2019) -
Anti-Aging and Depigmentation Effect of a Hyaluronic Acid Mechanically Stabilized Complex on Human Skin Explants
por: Siquier-Dameto, Gabriel, et al.
Publicado: (2023)